Home >> Neurological Research, Volume 31, Number 10

ERK1/2 activation in reactive astrocytes of mice with pilocarpine-induced status epilepticus

Authors: Li, Yu-Qin1; Xue, Tao1; Xu, Jing1; Xu, Zu-Cai2; Liu, Hua1; Chen, Yang-Mei1

Source: Neurological Research, Volume 31, Number 10, December 2009 , pp. 1108-1114(7)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Objective: To investigate the activation pattern of extracellular signal-regulated kinase 1/2 (ERK1/2) in the hippocampus of mice during pilocarpine-induced status epilepticus (SE) and its relationship with reactive astrogliosis.

Methods: Status epilepticus (SE) models were established by intraperitoneal injection of pilocarpine. The intervention group received the ERK1/2 signaling pathway inhibitor SL327 before the pilocarpine injection. We evaluated the SE model group, the intervention group and the control saline-treated group, at 6 hours and 3 days after initiation of the seizure. Phosphorylated activated ERK1/2 and glial fibrillary acidic protein (GFAP) were labeled with both single-labeling and sequential single-labeling immunohistochemical techniques.

Results: Among the pilocarpine-treated (SE model) mice, strong immunohistochemical staining of phospho-ERK1/2 was observed in the neurons and astrocytes of the hippocampus at 6 hours after initiation of SE, whereas staining on the third day of SE was not different from the control saline-treated mice. In the SL327-treated mice (intervention group), SL327 effectively blocked the ERK1/2 activation and little gliosis could be detected at 6 hours and 3 days after initiation of SE; the levels of phospho-ERK1/2 remained low, but the level of gliosis was similar to that of SE mice.

Conclusion: The ERK1/2 signaling pathway plays an important role in the early stage of reactive astrogliosis in mice with pilocarpine-induced SE.

Keywords: SEIZURE; ERK1/2; PILOCARPINE; HIPPOCAMPAL FORMATION

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/174313209X389839

Affiliations: 1: Department of Neurology, the Second Affiliated Hospital, Chongqing Medical University, Linjiang Road 76, Chongqing 400010, China 2: Department of Neurology, the First Affiliated Hospital, Zunyi Medical College, Zunyi 563003, China

Publication date: 2009-12-01

More about this publication?
Related content
Marked list

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page